The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Ferulic acid ethyl ester protects neurons against amyloid β‐ peptide(1–42)‐induced oxidative stress and neurotoxicity: relationship to antioxidant activity
Abstract
Alzheimer's disease (AD) is neuropathologically characterized by depositions of extracellular amyloid and intracellular neurofibrillary tangles, associated with loss of neurons in the brain. Amyloid β‐peptide (Aβ) is the major component of senile plaques and is considered to have a causal role in the development and progress of AD. Several lines of evidence suggest that enhanced oxidative stress and inflammation play important roles in the pathogenesis or progression of AD. The present study aimed to investigate the protective effects of ethyl‐4‐hydroxy‐3‐methoxycinnamic acid (FAEE), a phenolic compound which shows antioxidant and anti‐inflammatory activity, on Aβ(1–42)‐induced oxidative stress and neurotoxicity. We hypothesized that the structure of FAEE would facilitate radical scavenging and may induce protective proteins. Aβ(1–42) decreases cell viability, which was correlated with increased free radical formation, protein oxidation (protein carbonyl, 3‐nitrotyrosine), lipid peroxidation (4‐hydroxy‐2‐trans‐nonenal) and inducible nitric oxide synthase. Pre‐treatment of primary hippocampal cultures with FAEE significantly attenuated Aβ(1–42)‐induced cytotoxicity, intracellular reactive oxygen species accumulation, protein oxidation, lipid peroxidation and induction of inducible nitric oxide synthase. Treatment of neurons with Aβ(1–42) increases levels of heme oxygenase‐1 and heat shock protein 72. Consistent with a cellular stress response to the Aβ(1–42)‐induced oxidative stress, FAEE treatment increases the levels of heme oxygenase‐1 and heat shock protein 72, which may be regulated by oxidative stresses in a coordinated manner and play a pivotal role in the cytoprotection of neuronal cells against Aβ(1–42)‐induced toxicity. These results suggest that FAEE exerts protective effects against Aβ(1–42) toxicity by modulating oxidative stress directly and by inducing protective genes. These findings suggest that FAEE could potentially be of importance for the treatment of AD and other oxidative stress‐related diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506 · cited 1×
“Previous studies have indicated that small aggregates of Ab(1–42) play a critical role in the cytoxicity of this peptide (Drake et al. 2003b; Lambert et al. 1998; Walsh et al. 1999).”
BackgroundOxidative stress hypothesis in Alzheimer’s disease
Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383
Lim, G. P., Chu, T., Yang, F., Beech, W., Frautschy, S. A., & Cole, G. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08370.2001 · Cited by 1,530
Halliwell, B. (2001) · Drugs & Aging · doi:10.2165/00002512-200118090-00004 · Cited by 1,502
Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease
Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., & Perry, G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02653.1997 · Cited by 1,239
Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptide
Butterfield, D. A., Drake, J., Pocernich, C., & Castegna, A. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02173-6 · Cited by 1,114
Self-citationAmyloid β-Protein Fibrillogenesis
Walsh, D. M., Hartley, D. M., Kusumoto, Y., Fezoui, Y., Condron, M. M., Lomakin, A., Benedek, G. B., Selkoe, D. J., & Teplow, D. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25945 · Cited by 1,046
Antioxidant Properties of Ferulic Acid and Its Related Compounds
Kikuzaki, H., Hisamoto, M., Hirose, K., Akiyama, K., & Taniguchi, H. (2002) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf011348w · Cited by 1,017
Butterfield, D. A., & Lauderback, C. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00794-3 · Cited by 1,001
Self-citationOxidative stress in Alzheimer’s disease
Smith, M. A., Rottkamp, C. A., Nunomura, A., Raina, A. K., & Perry, G. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00040-5 · Cited by 895 · cited 2×
“…Braak and Braak 1997), has been attributed, to a large extent, to oxidative stress that may affect proteins, lipids and other cellular macromolecules (Behl 1997; Markesbery and Carney 1999; Smith et al. 2000; Varadarajan et al. 2000; Butterfield et al. 2001, 2002a; Butterfield and Lauderback 2002).”
BackgroundEndogenous nitric oxide synthesis: Biological functions and pathophysiology
Bredt, D. S. (1999) · Free Radical Research · doi:10.1080/10715769900301161 · Cited by 796
Allan Butterfield, D. (2002) · Free Radical Research · doi:10.1080/1071576021000049890 · Cited by 786
Oxidative Alterations in Alzheimer's Disease
Markesbery, W. R., & Carney, J. M. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00215.x · Cited by 784
Hensley, K., Hall, N., Subramaniam, R., Cole, P., Harris, M., Aksenov, M., Aksenova, M., Gabbita, S. P., Wu, J. F., Carney, J. M., et al. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65052146.x · Cited by 779 · cited 5×
“Involvement of oxidative stress, including protein oxidation, lipid peroxidation and 3-nitrotyrosine (3-NT) formation, has been reported in either AD brain samples or in experimental models of AD (Butterfield and Lauderback 2002; Hensley et al. 1995; Smith et al. 1997; Koppal et al. 1999; Aksenov et al. 2001; Butterfi…”
BackgroundInfluentialSelf-citationAlzheimer's Disease: A Central Role for Amyloid
Selkoe, D. J. (1994) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199409000-00003 · Cited by 751
Review: Alzheimer's Amyloid β-Peptide-Associated Free Radical Oxidative Stress and Neurotoxicity
Varadarajan, S., Yatin, S., Aksenova, M., & Butterfield, D. A. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4274 · Cited by 735
Self-citationALLANBUTTERFIELD, D., CASTEGNA, A., LAUDERBACK, C., & DRAKE, J. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00340-2 · Cited by 715
Markesbery, W. R., & Lovell, M. A. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00009-8 · Cited by 680
β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage
Koh, J.-Y., Yang, L. L., & Cotman, C. W. (1990) · Brain Research · doi:10.1016/0006-8993(90)91355-k · Cited by 617
Castegna, A., Aksenov, M., Aksenova, M., Thongboonkerd, V., Klein, J. B., Pierce, W. M., Booze, R., Markesbery, W. R., & Butterfield, D. A. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00914-0 · Cited by 581
Self-citationCastegna, A., Aksenov, M., Thongboonkerd, V., Klein, J. B., Pierce, W. M., Booze, R., Markesbery, W. R., & Butterfield, D. A. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01103.x · Cited by 581
Self-citationEvidence for a membrane defect in Alzheimer disease brain.
Nitsch, R. M., Blusztajn, J. K., Pittas, A. G., Slack, B. E., Growdon, J. H., & Wurtman, R. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1671 · Cited by 536
Proteomic identification of nitrated proteins in Alzheimer's disease brain
Castegna, A., Thongboonkerd, V., Klein, J. B., Lynn, B., Markesbery, W. R., & Butterfield, D. A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01786.x · Cited by 535
Self-citationHensley, K., Maidt, M. L., Yu, Z., Sang, H., Markesbery, W. R., & Floyd, R. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-20-08126.1998 · Cited by 507
Protein oxidation in the brain in Alzheimer's disease
Aksenov, M. Y., Aksenova, M. V., Butterfield, D. A., Geddes, J. W., & Markesbery, W. R. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00580-7 · Cited by 503
Self-citationKanski, J., Aksenova, M., Stoyanova, A., & Butterfield, D. A. (2002) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(01)00215-7 · Cited by 502
Self-citationLauderback, C. M., Hackett, J. M., Huang, F. F., Keller, J. N., Szweda, L. I., Markesbery, W. R., & Butterfield, D. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00451.x · Cited by 464
Self-citationAutopsy Samples of Alzheimer's Cortex Show Increased Peroxidation In Vitro
Subbarao, K. V., Richardson, J. S., & Ang, L. C. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb08858.x · Cited by 463
Acrolein is increased in Alzheimer’s disease brain and is toxic to primary hippocampal cultures
Lovell, M. A., Xie, C., & Markesbery, W. R. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00235-9 · Cited by 450
Cellular mechanisms of β-amyloid production and secretion
Sinha, S., & Lieberburg, I. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11049 · Cited by 437
Butterfield, D. A., & Kanski, J. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00249-4 · Cited by 419
Self-citationNutritional approaches to combat oxidative stress in Alzheimer’s disease
Butterfield, D. A., Castegna, A., Pocernich, C. B., Drake, J., Scapagnini, G., & Calabrese, V. (2002) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(02)00205-x · Cited by 403
Self-citationChapter 7 Protein Oxidation Processes in Aging Brain
Butterfield, D. A., & Stadtman, E. R. (1997) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(08)60057-7 · Cited by 390
Self-citationDrake, J. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00225-7 · Cited by 371
Butterfield, D. A. (1997) · Chemical Research in Toxicology · doi:10.1021/tx960130e · Cited by 364
Self-citationExpression of heme oxygenase‐1 in the senescent and alzheimer‐diseased brain
Schipper, H. M., Cissé, S., & Stopa, E. G. (1995) · Annals of Neurology · doi:10.1002/ana.410370609 · Cited by 356
(1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00056-1 · Cited by 330
Self-citationSvennerholm, L., & Gottfries, C. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62031039.x · Cited by 330
Caffeic Acid Phenethyl Ester and Curcumin: A Novel Class of Heme Oxygenase-1 Inducers
Scapagnini, G., Foresti, R., Calabrese, V., Stella, A. M. G., Green, C. J., & Motterlini, R. (2002) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12118-9 · Cited by 323
Self-citationMagrané, J., Smith, R. C., Walsh, K., & Querfurth, H. W. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4330-03.2004 · Cited by 242
Yatin, S. M., Varadarajan, S., & Butterfield, D. A. (2000) · Journal of Alzheimer's Disease · doi:10.3233/jad-2000-2212 · Cited by 239
Self-citationFree Radicals: Key to Brain Aging and Heme Oxygenase as a Cellular Response to Oxidative Stress
Poon, H. F., Calabrese, V., Scapagnini, G., & Butterfield, D. A. (2004) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/59.5.m478 · Cited by 236
Self-citationStaging of Alzheimer-Related Cortical Destruction
Braak, H., & Braak, E. (1997) · International Psychogeriatrics · doi:10.1017/s1041610297004973 · Cited by 217
Amyloid β-protein toxicity and oxidative stress in Alzheimer's disease
Behl, C. (1997) · Cell and Tissue Research · doi:10.1007/s004410050955 · Cited by 211
Premkumar, D. R. D., Smith, M. A., Richey, P. L., Petersen, R. B., Castellani, R., Kutty, R. K., Wiggert, B., Perry, G., & Kalaria, R. N. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65031399.x · Cited by 211
Carbonyl Toxicology and Alzheimer's Disease
Picklo, M. (2002) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2002.9506 · Cited by 194
Renkawek, K., Stege, G., & Bosman, G. C. G. M. (1999) · NeuroReport · doi:10.1097/00001756-199908020-00009 · Cited by 178
Calabrese, V., Scapagnini, G., Colombrita, C., Ravagna, A., Pennisi, G., Giuffrida Stella, A. M., Galli, F., & Butterfield, D. A. (2003) · Amino Acids · doi:10.1007/s00726-003-0048-2 · Cited by 176
Self-citationScapagnini, G., Butterfield, D. A., Colombrita, C., Sultana, R., Pascale, A., & Calabrese, V. (2004) · Antioxidants and Redox Signaling · doi:10.1089/1523086041798079 · Cited by 175
Self-citationKoppal, T., Drake, J., Yatin, S., Jordan, B., Varadarajan, S., Bettenhausen, L., & Butterfield, D. A. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720310.x · Cited by 167
Self-citationIncreased Expression but Reduced Activity of Antioxidant Enzymes in Alzheimer's Disease
Omar, R., Chyan, Y., Andorn, A. C., Poeggeler, B., Robakis, N. K. R. K., & Pappolla, M. A. (1999) · Journal of Alzheimer s Disease · doi:10.3233/jad-1999-1301 · Cited by 167
Protective role of heme oxygenase-1 in oxidative stress-induced neuronal injury
Le, W.-D., Xie, W.-J., & Appel, S. H. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990615)56:6<652::aid-jnr11>3.0.co;2-5 · Cited by 160
Apoptosis Decision Cascades and Neuronal Degeneration in Alzheimer’s Disease
Cotman, C. W. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00042-6 · Cited by 147
Increased synthesis and accumulation of heat shock 70 proteins in Alzheimer's disease
Perez, N., Sugar, J., Charya, S., Johnson, G. S., Merril, C. R., Bierer, L. M., Perl, D. P., Haroutunian, V. H., & Wallace, W. (1991) · Molecular Brain Research · doi:10.1016/0169-328x(91)90033-t · Cited by 138
Radical scavenging activity and cytotoxicity of ferulic acid.
Ogiwara, T., Satoh, K., Kadoma, Y., Murakami, Y., Unten, S., Atsumi, T., Sakagami, H., & Fujisawa, S. (2002) · PubMed · Cited by 137
Drake, J., Sultana, R., Aksenova, M. V., Calabrese, V., & Butterfield, D. A. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10810 · Cited by 124
Self-citationDrake, J., Kański, J., Varadarajan, S., Tsoras, M., & Butterfield, D. A. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10266 · Cited by 121
Self-citationKim, H., Cho, J.-Y., Kim, D.-H., Yan, J.-J., Lee, H., Suh, H., & Song, D. (2004) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.27.120 · Cited by 105
Dementia with β-amyloid deposition: involvement of αB-crystallin supports two main diseases
Lowe, J. S., Landon, M., Pike, I., Spendlove, I., McDermott, H., & Mayer, R. J. (1990) · The Lancet · doi:10.1016/0140-6736(90)92075-s · Cited by 103
Calabrese, V., Scapagnini, G., Ravagna, A., Fariello, R. G., Stella, A. M. G., & Abraham, N. G. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10177 · Cited by 103
Self-citationGridley, K. E., Green, P. S., & Simpkins, J. W. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.5.874 · Cited by 101
Butterfield, D. A., Yatin, S. M., Varadarajan, S., & Koppal, T. (1999) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(99)09050-3 · Cited by 99
Self-citationMcIntosh, L. J., Trush, M. A., & Troncoso, J. C. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00573-4 · Cited by 99
Sultana, R., Newman, S. F., Abdul, H. M., Keller, J. N., & Butterfield, D. A. (2004) · Free Radical Research · doi:10.1080/1071576042000206478 · Cited by 93
Self-citationHeat-shock protein 70 levels in brain of patients with Down Syndrome and Alzheimer’s disease
Yoo, B. C., Seidl, R., Cairns, N. J., & Lübec, G. (1999) · Springer eBooks · doi:10.1007/978-3-7091-6380-1_22 · Cited by 64
Park, C., Krishna, G. A., Ahn, M., Kang, J., Chung, W., Kim, D.-J., Hwang, H.-K., Lee, J., Paik, S., & Cha, Y. (2000) · Nitric Oxide · doi:10.1006/niox.2000.0300 · Cited by 53
Mechanisms of synaptic pathology in Alzheimer’s disease
Masliah, E. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6467-9_13 · Cited by 51
The Pathogenesis of Alzheimer's Disease: Is Amyloid β‐Protein the Beginning or the End?
Yankner, B. A. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05555.x · Cited by 36
Advances fuel Alzheimer's conundrum
Mattson, M. P. (1997) · Nature Genetics · doi:10.1038/ng1197-254 · Cited by 25
George‐Hyslop, P. S. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00020-7 · Cited by 24
Mattson, M. P., & Mattson, E. (2002) · Ageing Research Reviews · doi:10.1016/s1568-1637(02)00002-8 · Cited by 19
H�ggendal, J. (1982) · Journal of Neural Transmission · doi:10.1007/bf01243406 · Cited by 18
Possible Protective Mechanisms of Heme Oxygenase‐1 in the Brain
Takata, K., Kitamura, Y.-I., Kakimura, J., Shibagaki, K., Taniguchi, T., Gebicke‐Haerter, P. J., Smith, M. A., Perry, G. L., & Shimohama, S. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04857.x · Cited by 12
Cited by
Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity
Calabrese, V., Mancuso, C., Calvani, M., Rizzarelli, E., Butterfield, D. A., & Giuffrida Stella, A. M. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2214 · Cited by 1,543
Self-citationFerulic Acid: Therapeutic Potential Through Its Antioxidant Property
Srinivasan, M., Sudheer, A. R., & Menon, V. P. (2007) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.40.92 · Cited by 1,075
Potential applications of ferulic acid from natural sources
Kumar, N., & Pruthi, V. (2014) · Biotechnology Reports · doi:10.1016/j.btre.2014.09.002 · Cited by 962
Chemistry, natural sources, dietary intake and pharmacokinetic properties of ferulic acid: A review
Zhao, Z., & Moghadasian, M. H. (2008) · Food Chemistry · doi:10.1016/j.foodchem.2008.02.039 · Cited by 617
Ferulic acid: Pharmacological and toxicological aspects
Mancuso, C., & Santangelo, R. (2014) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.12.024 · Cited by 572
Metadata
- Authors
- Sultana, R., Ravagna, A., Mohmmad‐Abdul, H., Calabrese, V., & Butterfield, D. A.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2005-01-26
- Volume
- 92
- Issue
- 4
- Pages
- 749-758
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2163290644
- Cited by
- 276
- References
- 75
- FWCI
- 11.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.